ArticleACS pharmacology & translational science2024

Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2.

Yen-Ching Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.